| P50 | author | Gillian E Hanley | Q56528742 |
| P2093 | author name string | Dianne Miller | |
| | Sarah J Finlayson | |
| | Leslie Ann Sadownik | |
| | Marette H Lee | |
| | Ksenia Gukova | |
| P2860 | cites work | Behavior of moderate cervical dysplasia during long-term follow-up | Q71694143 |
| | Association of knowledge, anxiety, and fear with adherence to follow up for colposcopy | Q79272579 |
| | Adolescent cervical dysplasia: histologic evaluation, treatment, and outcomes | Q80774661 |
| | Increased risk of preterm birth after treatment for CIN | Q84938570 |
| | Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis | Q24647649 |
| | Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study | Q30307042 |
| | Reduced cervical cancer incidence and mortality in Canada: national data from 1932 to 2006. | Q30577708 |
| | Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis | Q33233738 |
| | Human papilloma virus, DNA methylation and microRNA expression in cervical cancer (Review). | Q33747273 |
| | Management options for cervical intraepithelial neoplasia | Q33949003 |
| | Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence | Q34176414 |
| | Colposcopic management of abnormal cervical cytology and histology | Q34508821 |
| | Natural history of histologically moderate cervical dysplasia in adolescent and young women. | Q34532180 |
| | Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women | Q34672882 |
| | p16 expression in the female genital tract and its value in diagnosis | Q36388823 |
| | The up-to-date evidence on colposcopy practice and treatment of cervical intraepithelial neoplasia: the Cochrane colposcopy & cervical cytopathology collaborative group (C5 group) approach | Q36606499 |
| | Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort | Q36695625 |
| | Risk factors for persistent cervical intraepithelial neoplasia grades 1 and 2: managed by watchful waiting | Q36840427 |
| | HPV16 CpG methyl-haplotypes are associated with cervix precancer and cancer in the Guanacaste natural history study | Q36901882 |
| | Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2 | Q37223672 |
| | Risks for cervical intraepithelial neoplasia 3 among adolescents and young women with abnormal cytology | Q37327018 |
| | Is the treatment of CIN 2 always necessary in women under 25 years old? | Q37922988 |
| | Pathways of vulvar intraepithelial neoplasia and squamous cell carcinoma | Q38063320 |
| | Premalignant lesions of the lower female genital tract: cervix, vagina and vulva | Q38084799 |
| | 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors | Q38091972 |
| | Molecular biomarkers in cervical cancer diagnosis: a critical appraisal. | Q38115352 |
| | Outcomes after management of young women with cervical intraepithelial neoplasia 2 with a 6-month observation protocol | Q38130117 |
| | Regression and Progression Predictors of CIN2 in Women Younger Than 25 Years | Q38839926 |
| | Methylation of the long control region of HPV16 is related to the severity of cervical neoplasia | Q39789073 |
| | Burden of cervical cancer in the United States, 1998-2003. | Q40030707 |
| | Natural history of cervical intraepithelial neoplasia: a critical review. | Q40891994 |
| | Recurrence of high-grade cervical abnormalities following conservative management of cervical intraepithelial neoplasia grade 2. | Q41591859 |
| | Observational Management of CIN 2 in Young Women: A Prospective Multicenter Trial | Q42048461 |
| | High-grade squamous intraepithelial lesion could be managed conservatively in women up to 25 years: results from a retrospective cohort study | Q43786609 |
| | Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities | Q44113435 |
| | ASCCP Colposcopy Standards: Risk-Based Colposcopy Practice | Q46902183 |
| | How distressing is referral to colposcopy in cervical cancer screening?: a prospective quality of life study | Q47958170 |
| | How many cervical cancers are prevented by treatment of screen-detected disease in young women? | Q51867350 |
| | The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. | Q51968734 |
| P433 | issue | 3 | |
| P304 | page(s) | 212-218 | |
| P577 | publication date | 2018-07-01 | |
| P1433 | published in | Journal of Lower Genital Tract Disease | Q15759785 |
| P1476 | title | Outcomes of Conservative Management of High Grade Squamous Intraepithelial Lesions in Young Women | |
| P478 | volume | 22 | |